ANVISA registration 10338930321Active

INFLIXIMAB (IFX)

Name: INFLIXIMAB (IFX) — ANVISA registration 10338930321
Creator: BIOSYNEX SA
Keywords: INFLIXIMAB (IFX), INFLIXIMAB (IFX), LISA-TRACKER INFLIXIMAB, 10338930321, Risk Class II, ANVISA registration

ANVISA Registration Number: 10338930321EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDABIOSYNEX SARisk Class II

Verified

Device names

Technical name: INFLIXIMAB (IFX)
Commercial name: LISA-TRACKER INFLIXIMAB
Risk class: Class II

Registration details

Registration Number: 10338930321
Process Number: 25351369552202466
CNPJ: 93741726000166

Company information

Registration Holder: EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA
Manufacturer: BIOSYNEX SA
Manufacturing Country: France

Dates and status

Publication Date: Aug 05, 2024
Validity: VIGENTE
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for INFLIXIMAB (IFX) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930321 and manufactured by BIOSYNEX SA. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.